Borex Capital is a premier venture capital and private equity firm that invests in the biotech, pharmaceutical, mining, cannabis, and AI space. We currently represent nearly 3,500 high net worth doctors and angel investors. We are headquartered in New York City.
| Website | http://www.borexcapital.com |
| Revenue | $200000 |
| Employees | 7 (5 on RocketReach) |
| Address | 122 E 42nd St, New York, New York 10168, US |
| Phone | +1 718-614-7315 |
| Industry | Financial Services, Finance General, Finance |
| Keywords | Venture Capital, Private Equity, Angel Investor Network, Healthcare Investing, Investment Fund, Pharmaceutical Investment, High Net Worth Investors, Mining Investment, Alternative Investments, Technology Investing, Portfolio Management, Capital Raising, Cannabis Investment, Growth Equity, Natural Resources Investment, Deal Sourcing, Early Stage Investing, Financial Services |
| Competitors | Gramercy Funds Management LLC, Winton, Aspect Capital, Two Sigma, Man Group, Highfields Capital, CQS, Capula Investment Management LLP, Moore Capital Management, Lansdowne Partners +26 more (view full list) |
| SIC | SIC Code 679 Companies, SIC Code 67 Companies |
| NAICS | NAICS Code 523 Companies, NAICS Code 52 Companies, NAICS Code 5239 Companies |
Looking for a particular Borex Capital employee's phone or email?
The Borex Capital annual revenue was $200000 in 2026.
Boris Mosheyev is the Founder and CEO of Borex Capital.
5 people are employed at Borex Capital.
Borex Capital is based in New York, New York.
The NAICS codes for Borex Capital are [523, 52, 5239].
The SIC codes for Borex Capital are [679, 67].